Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Equine Vet J ; 40(2): 171-7, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18089471

RESUMEN

REASON FOR PERFORMING STUDY: There are few detailed reports describing muscular disorders in Warmblood horses. OBJECTIVES: To determine the types of muscular disorders that occur in Warmblood horses, along with presenting clinical signs, associated risk factors and response to diet and exercise recommendations, and to compare these characteristics between horses diagnosed with polysaccharide storage myopathy (PSSM), those diagnosed with a neuromuscular disorder other than PSSM (non-PSSM) and control horses. METHODS: Subject details, muscle biopsy diagnosis and clinical history were compiled for Warmblood horses identified from records of biopsy submissions to the University of Minnesota Neuromuscular Diagnostic Laboratory. A standardised questionnaire was answered by owners at least 6 months after receiving the muscle biopsy report for an affected and a control horse. RESULTS: Polysaccharide storage myopathy (72/132 horses) was the most common myopathy identified followed by recurrent exertional rhabdomyolysis (RER) (7/132), neurogenic or myogenic atrophy (7/132), and nonspecific myopathic changes (14/132). Thirty-two biopsies were normal. Gait abnormality, 'tying-up', Shivers, muscle fasciculations and atrophy were common presenting clinical signs. Forty-five owners completed questionnaires. There were no differences in sex, age, breed, history or management between control, PSSM and non-PSSM horses. Owners that provided the recommended low starch fat supplemented diet and regular daily exercise reported improvement in clinical signs in 68% (19/28) of horses with a biopsy submission and 71% of horses diagnosed with PSSM (15/21). CONCLUSIONS: Muscle biopsy evaluation was a valuable tool to identify a variety of myopathies in Warmblood breeds including PSSM and RER. These myopathies often presented as gait abnormalities or overt exertional rhabdomyolysis and both a low starch fat supplemented diet and regular exercise appeared to be important in their successful management. POTENTIAL RELEVANCE: Warmbloods are affected by a variety of muscle disorders, which, following muscle biopsy diagnosis can be improved through changes in diet and exercise regimes.


Asunto(s)
Enfermedad del Almacenamiento de Glucógeno/veterinaria , Enfermedades de los Caballos/epidemiología , Atrofia Muscular/veterinaria , Enfermedades Musculares/veterinaria , Condicionamiento Físico Animal/fisiología , Rabdomiólisis/veterinaria , Almidón/administración & dosificación , Animales , Biopsia/veterinaria , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Enfermedad del Almacenamiento de Glucógeno/diagnóstico , Enfermedad del Almacenamiento de Glucógeno/epidemiología , Enfermedad del Almacenamiento de Glucógeno/terapia , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/terapia , Caballos , Masculino , Músculo Esquelético/patología , Atrofia Muscular/diagnóstico , Atrofia Muscular/epidemiología , Atrofia Muscular/terapia , Enfermedades Musculares/diagnóstico , Enfermedades Musculares/epidemiología , Enfermedades Musculares/terapia , Estudios Retrospectivos , Rabdomiólisis/diagnóstico , Rabdomiólisis/epidemiología , Rabdomiólisis/terapia , Factores de Riesgo , Almidón/metabolismo , Resultado del Tratamiento
2.
J Infect Dis ; 133(6): 603-12, 1976 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-180189

RESUMEN

The potential antiviral activity of 6-azauridine and 5-iododeoxyuridine was evaluated in a coordinated study at five institutions. Experimental models in five species, the mouse, rabbit, swine, cat, and ferret, were established with use of 10 viruses: Herpesvirus hominis types 1 and 2, murine cytomegalovirus, vaccinia virus, Shope fibroma virus, transmissible gastroenteritis virus, swine influenza virus, feline viral rhinotracheitis virus, feline panleukopenia virus, and ferret distemper virus. Criteria for selection were: (1) representation from a number of major groups of viruses, (2) reproduction of natural routes of infection, and (3) simulation of potentially treatable viral infections of man. Antiviral activity was observed for 5-iododeoxyuridine in H. hominis infections in hairless mice and influenza in swine, and a slight degree of efficacy was noted in rabbits infected with Shope fibroma virus. Toxicity was also observed in most of the experimental models. There was a suggestion of antiviral activity with 6-azauridine in swine infected with transmissible gastroenteritis virus; however, enhancement of disease and some toxicity were seen in most of the other models. Efficacy of these two compounds was not well substantiated by these studies.


Asunto(s)
Azauridina/uso terapéutico , Idoxuridina/uso terapéutico , Virosis/tratamiento farmacológico , Animales , Gatos , Infecciones por Citomegalovirus/tratamiento farmacológico , Moquillo/tratamiento farmacológico , Perros , Relación Dosis-Respuesta a Droga , Evaluación de Medicamentos , Panleucopenia Felina/tratamiento farmacológico , Femenino , Hurones , Gastroenteritis Porcina Transmisible/tratamiento farmacológico , Herpes Simple/tratamiento farmacológico , Virus de la Influenza A/efectos de los fármacos , Masculino , Ratones , Conejos , Rinitis/tratamiento farmacológico , Porcinos , Traqueítis/tratamiento farmacológico , Infecciones Tumorales por Virus/tratamiento farmacológico , Vaccinia/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...